SCHEMBL5161908

SCHEMBL5161908

O=S(=O)(NCCCCO)c1ccc(-c2c(F)c(F)c(F)c(F)c2F)cc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.55
PKM P14618 4/20 0.55
MEN1 O00255 1/20 0.55
KMT2A Q03164 1/20 0.55
HDAC4 P56524 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
LMNA P02545 3/20 0.48
KDM4E B2RXH2 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
GAA P10253 1/20 0.46
CYP2C19 P33261 1/20 0.44
HDAC1 Q13547 1/20 0.43
HDAC2 Q92769 1/20 0.43
TBXA2R P21731 2/20 0.42
CA12 O43570 1/20 0.42
CA2 P00918 1/20 0.42
CA9 Q16790 1/20 0.42
NPC1 O15118 1/20 0.42
MAPT P10636 1/20 0.42
HPGD P15428 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12570918 0.99 ALDH1A1 (0.58) ALDH1A1PKMMEN1KMT2AHDAC4
SCHEMBL2009359 0.85 ALDH1A1 (0.73) ALDH1A1PKMMEN1KMT2AHDAC4
SCHEMBL2008427 0.84 ALDH1A1 (0.76) ALDH1A1PKMMEN1KMT2AHDAC4
SCHEMBL2005591 0.80 ALDH1A1 (0.64) ALDH1A1PKMMEN1KMT2ALMNA
SCHEMBL2011664 0.80 GRIA4 (0.54) ALDH1A1PKMMEN1KMT2AHDAC4
SCHEMBL2011337 0.79 ALDH1A1 (0.55) ALDH1A1PKMMEN1KMT2AHDAC4
SCHEMBL2013461 0.79 ALDH1A1 (0.54) ALDH1A1PKMMEN1KMT2AHDAC4
SCHEMBL2004233 0.79 ALDH1A1 (0.67) ALDH1A1PKMMEN1KMT2ALMNA
SCHEMBL2009617 0.79 ALDH1A1 (0.67) ALDH1A1PKMMEN1KMT2ALMNA
SCHEMBL12570922 0.79 CA12 (0.63) ALDH1A1PKMMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1756046-A2 ARYL ALKYL SULFONAMIDES AS THERAPEUTIC AGENTS FOR THE TREATMENT OF BONE CONDITIONS The University Court of The University of Aberdeen (GB) 2007-02-28 EP disclosed
WO-2005118528-A2 ARYL ALKYL SULFONAMIDES AS THERAPEUTIC AGENTS FOR THE TREATMENT OF BONE CONDITIONS THE UNIVERSITY COURT OF THE UNIVERSITY OF ABERDEEN (GB) 2005-12-15 WO disclosed